Links/summaries 4 new Hep C Articles

August 27, 2011

Ahead of the Bell: Inhibitex rates 'outperform'

Forbes

By AP , 08.25.11, 09:23 AM EDT Inhibitex has a promising potential treatment for

the Hepatitis C virus, according to a Baird analyst who started coverage of the

biotechnology company with an " outperform " rating. J. Russo said in a

Thursday ...

See all stories on this topic »Buying Into a Hot Hepatitis C Drug Market

Minyanville.com

By Brett Chase Aug 25, 2011 1:15 pm Achillion Pharmaceuticals and Inhibitex are

speculative buys for investors hoping to tap the future demand for hepatitis C

treatments. Hepatitis C continues to be a hot area for drug development. ...

See all stories on this topic » Factoids about Hepatitis C

EmpowHer

By MC Kelby HERWriter August 25, 2011 - 6:13am Naomi Judd, Pamela ,

Crosby, Greg Allman, Tyler, Ken Wantanbe, Cole,

s and Jim Nabors are all currently living with the hepatitis C virus.

According to the Centers ...

See all stories on this topic » Drug Manufacturer Teva Ceases Propofol

Production Following $500M Award to Hep ...

Becker's ASC Review

By Fields | August 25, 2011 Generic drug manufacturer Teva ceased

propofol production three weeks after a jury awarded $500 million to a patient

who contracted hepatitis C from a procedure in which he received the anesthetic,

according to a ...

See all stories on this topic »

August 27, 2011